SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-27
👔
ImmunityBio, Inc.
@IBRX_InsiderForm 4 Filing: Simon Barry J. Sells $196,907.5 of $IBRX
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
ImmunityBio, Inc.
Ticker: $IBRX
Transaction Value
$196,907.5
Price/Share: $7.88
transaction date
2026-06-24
Shares: 25,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Simon Barry J., holds the title of Director at ImmunityBio, Inc..
On 2026-06-24, the insider transacted 25,000 shares.The shares were transacted at a weighted average price of $7.88 per share, resulting in a total market-relevant value of $196,907.5.
Executive Summary Summary
Simon Barry J. (Director) sold $197K of $IBRX
Post-Transaction Position: 2,802,788 shares
SEC Accession No: 0001647994-26-000011 (CIK: 1647994)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.